BUY IPCA Laboratories Limited — IDBI Capital
byIDBI CapitalHorizon: NA (inferred Swing (≤2wk))17 Sept 2026via IDBI Capital Research Calls Telegram
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Ipca Labs Rallies 50% on Q1 Growth; Analysts Flag Valuation Limits
NewsGoogle News·16 Sept · 2w ago
Krebs Biochemicals భారీ నష్టం.. Ipca Labs తో విలీనానికి గ్రీన్ సిగ్నల్!
NewsGoogle News·4 Sept · 3w ago
2 advisors have active short-term BUY calls on this stock
Advisor consensus · adjacent horizon·18 Aug · 1mo ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on IPCA Laboratories
- BUY — Amit Seth27 Oct 2026 · ~2 weeks · target ₹2,060 · SL hit
- BUY — Nilesh Jain, Centrum Broking27 Oct 2026 · ~2 weeks · target ₹2,040 · SL hit
- BUY — IDBI Capital27 Oct 2026 · ~2 weeks · target ₹2,066 · SL hit
- BUY — Sahi Research26 Oct 2026 · ~2 weeks · target ₹2,045 · SL hit
- BUY — Rakesh Bansal26 Oct 2026 · Same day · target ₹2,030 · SL hit
More from IDBI Capital
- BUY Alkem Laboratories6 Nov 2026 · ~2 weeks · target ₹5,460 · Active
- BUY Onesource Specialty Pharma6 Nov 2026 · ~2 weeks · target ₹1,735 · Active
- BUY Sun Pharmaceutical Industries6 Nov 2026 · ~2 weeks · target ₹1,925 · Active
- BUY Vijaya Diagnostic Centre6 Nov 2026 · ~2 weeks · target ₹1,575 · Active
- BUY Rolex Rings6 Nov 2026 · ~1 year · target ₹241 · Active

